Latest News

The long-awaited news is almost here, but seniors should keep their expectations in check.

One trades at a premium valuation but just turned profitable with 75% revenue growth; the other faces governance headwinds and shrinking sales.

Eli Lilly's stock price is comfortably above $1,000, and management could easily justify doing a stock split.

D-Wave is already generating revenue while QuantumScape remains pre-revenue, but both burn cash heavily, a critical distinction for growth investors weighing near-term execution against long-term potential.

Intel's turnaround is burning cash while NVIDIA's margins hit 55.6%, leaving investors to weigh recovery risk against dominance.

SpaceX is growing fast, and growth rates provide another perspective on valuation.

A Wendy's share costs less than a Baconator, hold the fries and drink. The new CEO is a turnaround expert, but he has a messy kitchen to clean up.

Insurance company Progressive (NYSE:PGR) will be reporting results this Wednesday before market hours. Here’s what you need to know. Progressive met analysts...

Financial services giant Bank of America (NYSE:BAC) will be announcing earnings results this Wednesday before market open. Here’s what to expect. Bank of Ame...

Regional banking company Home Bancshares (NYSE:HOMB) will be announcing earnings results this Wednesday after the bell. Here’s what you need to know. Home Ba...

Financial services giant State Street (NYSE:STT) will be reporting earnings this Wednesday before the bell. Here’s what to look for. State Street beat analys...

Global financial services firm Morgan Stanley (NYSE:MS) will be reporting earnings this Wednesday morning. Here’s what to look for. Morgan Stanley beat analy...

Amazon trades at a premium valuation despite stronger free cash flow, while Alibaba offers a cheaper entry point but faces regulatory headwinds in China.

Quarterly revenue at the AI chip leader is over five times what it was right before its big customer's first in-house chip debuted.

One company is profitable and raising its outlook. The other just hit a free cash flow milestone but is still working through a significant restructuring with heavy losses.

One platform is seeing AI spending translate directly into surging cloud revenue. The other is growing fast but navigating rising costs and a missed earnings quarter.

Carlos Henrique Villela Pedras doubled his direct stake, signaling confidence in the Brazilian bank despite modest recent returns.

Micron just increased its stock buyback authorization to $35.16 billion.

A researcher tracking the company raised its price target.

AbbVie trades at a 40% valuation discount but faces revenue concentration risk, while Eli Lilly's cardiometabolic dominance commands a premium.

Anduril is stealthily becoming a key producer of U.S. Navy submarines -- and also not so stealthily.

Investors weren't cheered by a major change in the company's leadership.

Paulo Roberto Simoes Da Cunha expanded his direct stake by 22%, bringing total holdings to ~265,000 shares at $17.98 per share.

Don't let shortsighted sellers distract you from this coin's real value.

An analyst made a significant price target cut.